The current status of diphenylhydantoin in heart disease.
D000758:Anesthesia / Q000009:adverse effects; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology; D006328:Cardiac Catheterization / Q000009:adverse effects; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D002319:Cardiovascular System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D004070:Digitalis; D004285:Dogs; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000188:drug therapy*; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D010276:Parasympatholytics / Q000494:pharmacology; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011343:Procaine / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology
D010276:Parasympatholytics; D011343:Procaine; D010672:Phenytoin; D011802:Quinidine